InsidersTradesSigma
Track the 삼아제약 stock price and the full management transaction log of the company, a publicly traded company based in South Korea. Shares trade on the KR market, under the supervision of DART (FSS). Operating in the Health Care sector, 삼아제약 has published 1 public disclosures. Market capitalisation: €74.6bn. The latest transaction was filed on 11 March 2026 (Other). Among the most active insiders: 삼아제약. All data is openly available.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Samah Pharmaceutical 是一家韩国制药公司，专注于药品的开发和制造。该公司在 XKRX 市场上市。